España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
DexCom
DXCM
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$88.78
-0.56
-0.63%
At close: -
$88.78
0.00
0.00%
After Hours: 4:05 PM EDT
Get Report
Comment
DexCom (DXCM) Forecast
News
Earnings
DexCom (DXCM) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for DexCom (NASDAQ:DXCM) Stock
DexCom Stock (NASDAQ: DXCM)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, February 14, 2025
Analyst Cautiously Optimistic On DexCom As Competitive Pressures Loom
Vandana Singh
DexCom Unusual Options Activity
Benzinga Insights
Stocks Head For Weekly Gains, US Treasury Yields Fall Below 4.5%: What's Driving Markets Friday?
Erica Kollmann
DexCom shares are trading higher after Morgan...
Benzinga Newsdesk
DexCom Analysts Increase Their Forecasts After Q4 Earnings
Avi Kapoor
Canaccord Genuity Maintains Buy on DexCom, Ra...
Benzinga Newsdesk
Morgan Stanley Maintains Equal-Weight on DexC...
Benzinga Newsdesk
Dexcom Q4 Earnings: Expanding Sales, New Products, Margin Pressure And More
Lekha Gupta
Thursday, February 13, 2025
DexCom shares are trading lower following a Q...
Benzinga Newsdesk
Dexcom Sees FY25 Adj. EBITDA Margin 30%; Reve...
Benzinga Newsdesk
DexCom Q4 2024 Adj. EPS $0.45 Misses $0.50 Es...
Benzinga Newsdesk
DexCom Options Trading: A Deep Dive into Market Sentiment
Benzinga Insights
Earnings Scheduled For February 13, 2025
Benzinga Insights
Monday, February 03, 2025
Deep Dive Into DexCom Stock: Analyst Perspectives (5 Ratings)
Benzinga Insights
Redburn Atlantic Upgrades DexCom to Buy, Rais...
Benzinga Newsdesk
Thursday, January 16, 2025
Expert Outlook: DexCom Through The Eyes Of 11 Analysts
Benzinga Insights
Lululemon To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Thursday
Avi Kapoor
This Netflix Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
Avi Kapoor
DexCom shares are trading higher after Baird ...
Benzinga Newsdesk
Baird Upgrades DexCom to Outperform, Raises P...
Benzinga Newsdesk
Monday, January 13, 2025
DexCom shares are trading higher after the co...
Benzinga Newsdesk
DexCom Currently Anticipates FY25 Total Reven...
Benzinga Newsdesk
DexCom Expects Q4 Total Revenue Of At Least $...
Benzinga Newsdesk
Monday, January 06, 2025
Decoding DexCom's Options Activity: What's the Big Picture?
Benzinga Insights
Monday, December 30, 2024
Smart Money Is Betting Big In DXCM Options
Benzinga Insights
Monday, December 23, 2024
Abbott And DexCom Settle Global Patent Disput...
Benzinga Newsdesk
Friday, December 20, 2024
Benzinga Market Summary: S&P Rises On PCE Dat...
Benzinga Newsdesk
Shares of glucose monitoring stocks are tradi...
Benzinga Newsdesk
Tuesday, December 17, 2024
Dexcom Launched Proprietary Generative AI Pla...
Benzinga Newsdesk
Monday, December 16, 2024
Peering Into DexCom's Recent Short Interest
Benzinga Insights
Wednesday, December 11, 2024
Citigroup Maintains Buy on DexCom, Raises Pri...
Benzinga Newsdesk
Wells Fargo Maintains Overweight on DexCom, R...
Benzinga Newsdesk
Tuesday, December 10, 2024
Watching Shares Of DexCom; Traders Circulatin...
Benzinga Newsdesk
Monday, December 09, 2024
Key Takeaways From DexCom Analyst Ratings
Benzinga Insights
Canaccord Genuity Maintains Buy on DexCom, Ra...
Benzinga Newsdesk
Monday, December 02, 2024
Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos
Vandana Singh
Tuesday, November 19, 2024
DexCom, ŌURA Enter Strategic Partnership; Dex...
Benzinga Newsdesk
Monday, November 18, 2024
DexCom's Options Frenzy: What You Need to Know
Benzinga Insights
Thursday, November 14, 2024
Tiger Global Hedge Fund Buys Flutter Entertainment Stock, Sells DexCom
Erica Kollmann
Friday, October 25, 2024
Analyst Expectations For DexCom's Future
Benzinga Insights
These Analysts Revise Their Forecasts On DexCom Following Q3 Results
Avi Kapoor
Bernstein Maintains Outperform on DexCom, Rai...
Benzinga Newsdesk
Raymond James Maintains Strong Buy on DexCom,...
Benzinga Newsdesk
Tech Stocks Rally As Investors Await Magnificent 7 Earnings; Dollar Eyes Fourth Straight Positive Week: What's Driving Markets Friday?
Piero Cingari
RBC Capital Maintains Outperform on DexCom, L...
Benzinga Newsdesk
'Apple Staff Tests Blood-Sugar App In Sign Of...
Benzinga Newsdesk
Oppenheimer Maintains Outperform on DexCom, L...
Benzinga Newsdesk
JP Morgan Maintains Neutral on DexCom, Raises...
Benzinga Newsdesk
Leerink Partners Maintains Outperform on DexC...
Benzinga Newsdesk
Capri, Coursera, DexCom And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Avi Kapoor
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch